Explore evidence

38.2 %38.2% of parents/caregivers in Kenya reported that age-eligible girl(s) in their household had received any doses of the HPV vaccine.

Kenyainfection à HPVobserved 2022published 2024VaccinePubMeddocument of 2 observations

3 %The weighted national HBV prevalence was 3.0% (95% CI: 2.2–3.9%).

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations

23 %In Nairobi, the increase in knowledge of HIV status attributable to DREAMS was 23% among adolescent girls and young women aged 18–22 years in 2017.

KenyaVIH/sidaobserved 2017published 2022Journal of epidemiology and community healthPubMeddocument of 6 observations

1 per_317Among 317 women, CIN1 controls included HPV53 and 66 coinfection in 1/317 (0.3%).

KenyaCIN1published 2021BioMed research internationalPubMeddocument of 9 observations

Children who slept under permethrin-treated bed nets had significantly fewer episodes of clinical malaria than control children.

Kenyapaludismeobserved 1985published 1987Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 4 observations

4.46 per_100000In 2015, there were 2,072 microscopy sites in Kenya, with a mean microscopy density of 4.46 per 100,000 inhabitants.

Kenyatuberculoseobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations

13 %Among 31 women treated for trichomoniasis, the concentration of vaginal HIV-1 RNA was above the limit for quantitation before infection in 4 women (13%).

Kenyatrichomoniasis · VIH/sidapublished 2011BMC infectious diseaseseurope_pmcdocument of 5 observations

69 %In consensus review results, 69% of CIN 2 cases were p16INK4a positive.

KenyaCIN 2published 2021The Pan African medical journalPubMeddocument of 11 observations

71 %Among 411 participants with new Kaposi sarcoma diagnoses in Kenya and Uganda between 2016 and 2019, 71% were men.

Kenyasarcome de Kaposiobserved 2016 to 2019published 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

23.2 %The age-specific adjusted HIV prevalence among people who inject drugs who initiated injecting at ages 20–24 years in the coastal region was 23.2%.

KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 17 observations

2 casesAetiology-confirmed meningitis was reported in two children: one case of bacterial meningitis due to Streptococcus pneumoniae in an RTS,S/AS01-vaccinated child and one case of viral meningitis due to human herpesvirus 6 in an unvaccinated child.

Kenyaméningite (non précisée)published 2025The Lancet. Global healthPubMeddocument of 10 observations

44.9 %Of 49 women with suspicious lesions on mammography, 22 (44.9%) had been linked to care 4 months after the campaign.

Kenyacancer du seinpublished 2022Cancer reports (Hoboken, N.J.)PubMeddocument of 17 observations

61.1 %The mean completeness score of HIV data from 187 care facilities in Kenya was 61.1%.

KenyaVIH/sidaobserved January 2011 to June 2018published 2023BMC health services researchPubMeddocument of 3 observations

81 women_per_monthIn Kenya, identification, management, and response for female survivors of gender-based violence increased from an average of 81 to 364 women per month.

Kenyagender-based violencepublished 2022Global health, science and practicePubMeddocument of 8 observations

59.4 %Among HIV-positive patients with cancer, 59.4% (19 of 32) had a non-AIDS-defining cancer (NADC).

Kenyanon-AIDS-defining cancer · VIH/sidapublished 2023JCO global oncologyPubMeddocument of 8 observations

1,988 participants1988 participants were recruited between March 14, 2019, and November 26, 2020.

KenyaVIH/sidaobserved March 14, 2019 to November 26, 2020published 2023The lancet. HIVPubMeddocument of 8 observations

60 %In anophelines, bovine blood was 60.0% in houses.

Kenyapaludismepublished 2025Parasites & vectorsPubMeddocument of 6 observations

51.4 %More than half (51.4%) of cancer outpatients at Kenyatta National Hospital and Texas Cancer Centre were diagnosed at stage 3 or stage 4.

Kenyacancer (non précisé)published 2018Double Burden of Malnutrition among Cancer Outpatients in Nairobi, Kenya: Challenges and OOpenAlexdocument of 8 observations

5.2 odds_ratioHIV infection was associated with preferring a sex partner of any age—younger, same or older (adjusted odds ratio = 5.2; 95% CI: 1.1–25.2, p = 0.041).

KenyaVIH/sidaobserved 2021published 2023AIDS research and therapyPubMeddocument of 14 observations

24 %Perception of high HIV risk among uncircumcised controls declined from 24% to 21%.

KenyaVIH/sidapublished 2014AIDS and behavioreurope_pmcdocument of 5 observations

20 %20% of the adolescents and young adults living with HIV reported that disclosure positively influenced their communication with caregivers.

KenyaVIH/sidaobserved 2019published 2023Frontiers in public healthPubMeddocument of 18 observations

Active case search data from June 2026 revealed a high burden of unreported suspected VPDs, primarily measles, concentrated in the East and Southern Africa Block (Mozambique, Malawi, Tanzania, Ethiopia, Kenya, Zambia, and Madagascar), in the DRC-Angola Block (DRC and Angola), in the West Block (Benin, Togo and Guinea), and in the Lake Chad Basin (Nigeria, Chad, Cameroon and Central African Republic).

Angola · Bénin · Cameroun · Éthiopie · Guinée · Kenya · Madagascar · Malawi · Mozambique · Nigeria · RDC · Tanzanie · Tchad · Togo · Zambierougeole · VPDsobserved June 2026WHO Africadocument of 17 observations

24.5 %Prevalence of moderate-to-severe depressive symptoms was 24.5% in pregnancy and 6.8% post partum among Kenyan women in this cohort.

Kenyadepressive symptomspublished 2022The lancet. PsychiatryPubMeddocument of 9 observations

TB is the leading cause of mortality among people living with HIV (PLHIV).

Kenyatuberculosepublished 2021The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 10 observations

45 introductionsLineage B.1 accounted for 45 of the 76 SARS-CoV-2 introductions into Kenyan coast.

KenyaB.1 lineage · COVID-19published 2020Tracking the introduction and spread of SARS-CoV-2 in coastal Kenyaeurope_pmcdocument of 3 observationsDOI 10.21203/rs.3.rs-93975/v1